Nano-vesicles for Improving Drug’s Stability and Efficacy to Treat Chronic Diseases
Diabetes and asthma are common chronic diseases. According to the World Health Organization (WHO) report, it was estimated that 420 million people had diabetes and more than 339 million people suffer from asthma globally in 2016. It is estimated that in 2012, 24 million and 1.5 million people died of complications caused by diabetes and asthma respectively.
Currently, there is no permanent cure for diabetes and asthma, patients can only take drugs to prevent the onset of disease and relieve the pain temporarily. However, diabetes and asthma drugs will be quickly metabolized by the human body and the therapeutic effect of active pharmaceutical ingredients can only last for a short period. Also, the patients may need to take a higher dosage of the drug to offset the loss of pharmaceutical ingredients before they reach the target site on the body.
We have developed a new protective layer manufacturing technology with high encapsulation efficiency, which allows the control of the release and delivery of active pharmaceutical ingredients. It can prolong the therapeutic effect of drugs, increase the drug retention time in the body, and eventually reduce the dosage, systemic side effects and toxicity of the drugs.